Jupiter Neurosciences, Inc. SEC filings JUNS
Jupiter Neurosciences, Inc. has 203 filings in SEC EDGAR's recent list, going back to Jul 15, 2016. Its latest annual report, Form ARS, was filed on Jun 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 3, 2026 (bylaw or fiscal year change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Oct 13, 2026 | — |
| S-3 | Shelf registration | Sep 25, 2026 | — |
| 424B5 | Prospectus supplement | Aug 24, 2026 | — |
| 424B3 | Prospectus | Jul 29, 2026 | — |
| 424B3 | Prospectus | Jul 27, 2026 | — |
| 424B3 | Prospectus | Jul 21, 2026 | — |
| 424B3 | Prospectus | Jun 30, 2026 | — |
| S-1 | Registration statement | Jun 26, 2026 | — |
| 424B3 | Prospectus | Jun 22, 2026 | — |
| 424B3 | Prospectus | Jun 5, 2026 | — |
| 424B3 | Prospectus | May 21, 2026 | — |
| 424B3 | Prospectus | May 21, 2026 | — |
| 424B5 | Prospectus supplement | May 21, 2026 | — |
| 424B3 | Prospectus | May 20, 2026 | — |
| 424B3 | Prospectus | May 14, 2026 | — |
| 424B3 | Prospectus | May 8, 2026 | — |
| S-3 | Shelf registration | Apr 16, 2026 | — |
| S-8 | Employee stock plan registration | Feb 13, 2026 | — |
| 424B3 | Prospectus | Dec 19, 2025 | — |
| S-1 | Registration statement | Nov 26, 2025 | — |
| 424B3 | Prospectus | Dec 2, 2024 | — |
| 424B4 | Prospectus | Dec 2, 2024 | — |
| S-1/A | Amended registration statement | Oct 18, 2024 | — |
| S-1/A | Amended registration statement | Sep 13, 2024 | — |
| S-1/A | Amended registration statement | Sep 4, 2024 | — |
| S-1/A | Amended registration statement | Sep 4, 2024 | — |
| S-1/A | Amended registration statement | Jul 12, 2024 | — |
| S-1/A | Amended registration statement | Jan 17, 2023 | — |
| S-1/A | Amended registration statement | Jan 6, 2023 | — |
| S-1/A | Amended registration statement | Dec 7, 2022 | — |
| S-1/A | Amended registration statement | Dec 2, 2022 | — |
| S-1/A | Amended registration statement | Aug 26, 2022 | — |
| S-1/A | Amended registration statement | Aug 16, 2022 | — |
| S-1/A | Amended registration statement | May 18, 2022 | — |
| S-1/A | Amended registration statement | May 5, 2022 | — |
| S-1/A | Amended registration statement | May 4, 2022 | — |
| S-1/A | Amended registration statement | Apr 26, 2022 | — |
| S-1/A | Amended registration statement | Feb 3, 2022 | — |
| S-1/A | Amended registration statement | Feb 3, 2022 | — |
| S-1/A | Amended registration statement | Jan 26, 2022 | — |
| S-1/A | Amended registration statement | Jan 5, 2022 | — |
| S-1/A | Amended registration statement | Dec 23, 2021 | — |
| S-1/A | Amended registration statement | Dec 17, 2021 | — |
| S-1/A | Amended registration statement | Nov 9, 2021 | — |
| S-1 | Registration statement | Oct 12, 2021 | — |
Showing 45 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- JUNS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Jupiter, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1679628
- Former names
- Jupiter Orphan Therapeutics, Inc. (until Dec 5, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.